Skip to main content
Premium Trial:

Request an Annual Quote

Ken Welsh, Vladimir Vapnik, Jeffrey Stafford, and Steadman Harrison


Ken Welsh has been appointed to the scientific advisory board of Health Discovery Corporation, a biotechnology company focused on biomarker and pathway discovery for diagnostic markers and drug targets. Welsh is currently a professor of clinical genomics at Royal Brompton Hospital and Imperial College in London. He is also a science advisor to the West London Transplant Center, and a visiting professor at Oxford University and the University of Utrecht. He received a BSc, PhD, and DSc from Newcastle University.

Health Discovery Corporation also has named Vladimir Vapnik to its scientific advisory board. Vapnik, who won the Humboldt Research award in 2003, is currently a senior researcher at NEC Research. He has worked for AT&T Bell Laboratories and AT&T Labs-Research.

Syrrx has promoted Jeffrey Stafford to vice president of chemistry. Stafford joined the company in 2002 as senior director of chemistry following an 11-year tenure at Glaxo SmithKline, where he held the position of director of chemistry in oncology. Syrrx said Stafford’s team will primarily concentrate on structure-based, small-molecule lead generation and optimization.

Steadman Harrison has been named senior research director and executive director of research and development at PPD’s Piedmont Research Center for preclinical cancer research. Harrison’s responsibilities will include designing, conducting, and interpreting research studies in the areas of tumor biology, biochemistry, and pharmacology, the company said.

Harrison was previously the executive director of experimental medicine and executive director of business development at EMD Pharmaceuticals (Merck KGaA). He has served on the faculties of the University of Kentucky Center for Toxicology and the University of Alabama at Birmingham, and is currently an adjunct faculty member at Duke University. Harrison holds a PhD in pharmacology from Indiana University.


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.